Ellison Medical Institute
- Biotech or pharma, therapeutic R&D
- Institute, hospital research
The Ellison Medical Institute (EMI), led by Founding CEO Dr. David Agus, is leveraging a robust clinical infrastructure and interdisciplinary research ecosystem to drive the discovery and development of next-generation therapeutics in oncology — with an initial focus on clinically-validated targets in breast and prostate cancers. We currently have multiple programs in hit-to-lead and lead optimization stages, supported by state-of-the-art AI-driven drug discovery platforms and preclinical models.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}